Samsung Ventures will exit DNA identification platform IntegenX, which had raised almost $104m in funding, in an acquisition by Thermo Fisher Scientific.
US-based forensic DNA analysis platform developer IntegenX was acquired by biotechnology firm Thermo Fisher Scientific today for an undisclosed sum, allowing electronics producer Samsung to exit.
Founded in 2006 and spun out of University of California (UC) Berkeley, IntegenX has created a rapid human DNA identification platform that deploys advanced fluidics, optics and biochemistry to help forensic researchers and law enforcement agencies generate DNA profiles from samples within 90 minutes.
Thermo Fisher will use IntegenX’s products to augment its own…
